Evidence map›Paper›PMID 34313875›Full record

ArticleCancer causes & control : CCC2021

Communication research at the National Cancer Institute, 2013-2019: a grant portfolio analysis.

Anna Gaysynsky, Camella J Rising, Neha Trivedi, Kelly D Blake, Wen-Ying Sylvia Chou, April Oh, Robin C Vanderpool

Open access · greenAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Impact of a Cancer Survivorship Continuing Medical Education Course on Learners' Attitudes and Intention to Change Practice.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Digital Tools and Strategies for Engaging Patients in Cancer Clinical Trials.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna GaysynskyHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA. anna.gaysynsky@nih.gov.ORCID http://orcid.org/0000-0001-5612-5572
Camella J RisingHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA.ORCID http://orcid.org/0000-0002-4099-528X
Neha TrivediHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA.
Kelly D BlakeHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA.
Wen-Ying Sylvia ChouHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA.
April OhImplementation Science Team, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, 20850, USA.
Robin C VanderpoolHealth Communication and Informatics Research Branch, Division of Cancer Control and Population Sciences, 9609 Medical Center Drive, National Cancer Institute, Rockville, MD, 20850, USA.ORCID http://orcid.org/0000-0001-9995-4485
National Cancer Institute · US

Funding

ICF Inc. #HHSN261201400002BIntramural NIH HHS Z99 CA999999NCI NIH HHS HHSN261201400002BNCI NIH HHS HHSN261201400002C
6 · The paper itself

Abstract

purposeTo analyze communication-focused grants funded by the National Cancer Institute (NCI) between fiscal years 2013 and 2019 to provide insight into the characteristics of funded projects and identify promising areas for future research.

methodsiSearch, a portfolio analysis tool, was queried to identify communication-related grants funded by NCI. Abstracts and specific aims were coded for key study characteristics. 344 unique competing grants with a substantial communication component were included in the final analysis. SAS version 9.4 was used to calculate code frequencies.

resultsMost communication grants focused on cancer prevention (n = 197), with fewer targeting diagnosis, treatment, survivorship, or end-of-life. Tobacco product use was the most frequently addressed topic (n = 128). Most grants targeted or measured outcomes at the individual (n = 332) or interpersonal level (n = 127). Cancer patients/survivors (n = 101) and healthcare providers (n = 63) were often the population of focus, while caregivers or those at increased risk for cancer received less attention. Studies were often based in healthcare settings (n = 125); few studies were based in schools or worksites. Many grants employed randomized controlled trials (n = 168), but more novel methods, like optimization trials, were uncommon.

conclusionNCI's support of health communication research covers a diverse array of topics, populations, and methods. However, the current analysis also points to several promising opportunities for future research, including efforts focused on communication at later stages of the cancer control continuum and at multiple levels of influence, as well as studies that take advantage of a greater diversity of settings and leverage novel methodological approaches.

Indexed as

Biomedical ResearchNeoplasmsFinancing, OrganizedHumansInterdisciplinary CommunicationNational Cancer Institute (U.S.)National Institutes of Health (U.S.)SurvivorshipUnited StatesCancer controlHealth communicationNational Cancer InstitutePortfolio analysisResearch funding

Identifiers

PMID34313875
PMCPMC12754849
OpenAlexW3186552501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.